Ferric carboxymaltose with or without phosphate substitution in iron deficiency or iron deficiency anemia before elective surgery – The DeFICIT trial
Co-administration of oral phosphate supplementation to ferric carboxymaltose cannot prevent hypophosphatemia. However, hypophosphatemia occurs in fewer patients. Phosphate co-administration did not impede the treatment of iron deficiency anemia with ferric carboxymaltose.
Authors
- Andreas J. Hülsmeier
- Heike A. Bischoff‐Ferrari (ORCID: https://orcid.org/0000-0002-4554-658X)
- Matthias Turina (ORCID: https://orcid.org/0000-0002-1040-3511)
- Julian Rössler (ORCID: https://orcid.org/0000-0002-7601-6493)
- Gergely Karsai (ORCID: https://orcid.org/0000-0002-6840-682X)
- Alexander Mair
- Samira Akbas (ORCID: https://orcid.org/0000-0001-7692-4718)
- Greta Gasciauskaite (ORCID: https://orcid.org/0000-0003-4963-8489)
- Julia Braun (ORCID: https://orcid.org/0000-0001-8359-6177)
- Donat R. Spahn (ORCID: https://orcid.org/0000-0002-4782-183X)
- Pierre–Alain Clavien (ORCID: https://orcid.org/0000-0002-9916-7905)
- Isabelle Opitz (ORCID: https://orcid.org/0000-0001-5900-9040)
- Alexander Kaserer (ORCID: https://orcid.org/0000-0001-9105-8328)
- Gabriela H. Spahn
- Martin Schläpfer
Institutions
- University of Zurich (CH)
- University Hospital of Zurich (CH)
Publication Details
- Journal
- Journal of Clinical Anesthesia
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1016/j.jclinane.2024.111727
- Citations
- 3
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.02
Funders
- Swiss Foundation for Anesthesia Research
- Vifor Pharma